| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3956398 | Journal of Minimally Invasive Gynecology | 2014 | 24 Pages |
Abstract
Low-dose aspirin does not influence the risk of bleeding and hemorrhagic complications in endometrial cancer patients undergoing minimally invasive staging. Hence, the choice to continue or cease the use of low-dose aspirin should be guided only by perioperative cardiovascular risk stratification.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Giorgio MD, Antonella PhD, Stefano MD, Maurizio MD, Jvan MD, Ciro MD, Fabio MD,